AIM: To test the role of the Beclin 1-dependent autophagy pathway in brain damage during cerebral ischemia. METHODS: Focal cerebral ischemia was established in rats using a middle cerebral artery occlusion (MCAO) model. A lentiviral vector-associated RNA interference (RNAi) system was stereotaxically injected into the ipsilateral lateral ventricle to reduce Beclin1 expression. We measured the ipsilateral infarct volume, autophagosome formation, neurogenesis and apoptosis, all of which could be modulated by Beclin1 RNAi. RESULTS: On the 14th day after MCAO, Beclin1 downregulation by RNAi increased the population of neural progenitor cells (BrdU(+)-DCX(+)), newborn immature cells (BrdU(+)-Tuj-1(+)) and mature neurons (BrdU(+)-MAP-2(+)), and reduced the apoptosis of immature neurons (caspase-3(+)-DCX(+) and caspase-3(+)-Tuj-1(+)) surrounding the ischemic core of the ipsilateral hemisphere. Furthermore, RNAi-mediated downregulation of Beclin1 decreased infarct volume and inhibited histological injury and neurological deficits. CONCLUSION: RNAi-mediated downregulation of Beclin1 improves outcomes after transient MCAO.Acta Pharmacologica Sinica (2009) 30: 919-927; doi: 10.1038/aps.2009.79.
AIM: To test the role of the Beclin 1-dependent autophagy pathway in brain damage during cerebral ischemia. METHODS: Focal cerebral ischemia was established in rats using a middle cerebral artery occlusion (MCAO) model. A lentiviral vector-associated RNA interference (RNAi) system was stereotaxically injected into the ipsilateral lateral ventricle to reduce Beclin1 expression. We measured the ipsilateral infarct volume, autophagosome formation, neurogenesis and apoptosis, all of which could be modulated by Beclin1 RNAi. RESULTS: On the 14th day after MCAO, Beclin1 downregulation by RNAi increased the population of neural progenitor cells (BrdU(+)-DCX(+)), newborn immature cells (BrdU(+)-Tuj-1(+)) and mature neurons (BrdU(+)-MAP-2(+)), and reduced the apoptosis of immature neurons (caspase-3(+)-DCX(+) and caspase-3(+)-Tuj-1(+)) surrounding the ischemic core of the ipsilateral hemisphere. Furthermore, RNAi-mediated downregulation of Beclin1 decreased infarct volume and inhibited histological injury and neurological deficits. CONCLUSION: RNAi-mediated downregulation of Beclin1 improves outcomes after transient MCAO.Acta Pharmacologica Sinica (2009) 30: 919-927; doi: 10.1038/aps.2009.79.
Authors: Y Kabeya; N Mizushima; T Ueno; A Yamamoto; T Kirisako; T Noda; E Kominami; Y Ohsumi; T Yoshimori Journal: EMBO J Date: 2000-11-01 Impact factor: 11.598
Authors: Faisal Adhami; Guanghong Liao; Yury M Morozov; Aryn Schloemer; Vincent J Schmithorst; John N Lorenz; R Scott Dunn; Charles V Vorhees; Marsha Wills-Karp; Jay L Degen; Roger J Davis; Noboru Mizushima; Pasko Rakic; Bernard J Dardzinski; Scott K Holland; Frank R Sharp; Chia-Yi Kuan Journal: Am J Pathol Date: 2006-08 Impact factor: 4.307
Authors: Dun-Sheng Yang; Asok Kumar; Philip Stavrides; Jesse Peterson; Corrine M Peterhoff; Monika Pawlik; Efrat Levy; Anne M Cataldo; Ralph A Nixon Journal: Am J Pathol Date: 2008-08-07 Impact factor: 4.307
Authors: Francesco Cecconi; Sabrina Di Bartolomeo; Roberta Nardacci; Claudia Fuoco; Marco Corazzari; Luigi Giunta; Alessandra Romagnoli; Anastassia Stoykova; Kamal Chowdhury; Gian Maria Fimia; Mauro Piacentini Journal: Autophagy Date: 2007-06-21 Impact factor: 16.016
Authors: Lorenzo Galluzzi; José Manuel Bravo-San Pedro; Beth Levine; Douglas R Green; Guido Kroemer Journal: Nat Rev Drug Discov Date: 2017-05-19 Impact factor: 84.694